[go: up one dir, main page]

MX2018013673A - Ensayo para determinar nivel de carbonilacion total en un polipeptido. - Google Patents

Ensayo para determinar nivel de carbonilacion total en un polipeptido.

Info

Publication number
MX2018013673A
MX2018013673A MX2018013673A MX2018013673A MX2018013673A MX 2018013673 A MX2018013673 A MX 2018013673A MX 2018013673 A MX2018013673 A MX 2018013673A MX 2018013673 A MX2018013673 A MX 2018013673A MX 2018013673 A MX2018013673 A MX 2018013673A
Authority
MX
Mexico
Prior art keywords
polypeptide
determining
assay
carbonylation level
total carbonylation
Prior art date
Application number
MX2018013673A
Other languages
English (en)
Inventor
Mah Anna
Yang Yi
Gao Di
A Gennaro Lynn
Schoeneich Christian
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of MX2018013673A publication Critical patent/MX2018013673A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/583—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with non-fluorescent dye label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2440/00—Post-translational modifications [PTMs] in chemical analysis of biological material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La descripción se refiere a un método y kits para determinar el nivel de carbonilación total en un polipéptido.
MX2018013673A 2016-05-19 2017-05-18 Ensayo para determinar nivel de carbonilacion total en un polipeptido. MX2018013673A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662338605P 2016-05-19 2016-05-19
PCT/US2017/033371 WO2017201312A1 (en) 2016-05-19 2017-05-18 Assay for determining the total carbonylation level on a polypeptide

Publications (1)

Publication Number Publication Date
MX2018013673A true MX2018013673A (es) 2019-05-02

Family

ID=59014741

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018013673A MX2018013673A (es) 2016-05-19 2017-05-18 Ensayo para determinar nivel de carbonilacion total en un polipeptido.

Country Status (12)

Country Link
US (1) US11371999B2 (es)
EP (1) EP3458855B1 (es)
JP (1) JP6970122B2 (es)
KR (1) KR102408263B1 (es)
CN (1) CN109154597B (es)
AU (1) AU2017267726B2 (es)
BR (1) BR112018069072A2 (es)
CA (1) CA3013668A1 (es)
IL (1) IL262322B2 (es)
MX (1) MX2018013673A (es)
SG (1) SG11201807313PA (es)
WO (1) WO2017201312A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113138206B (zh) * 2021-03-04 2022-04-19 宁波大学 一种鉴别氨基酸的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362852A (en) * 1991-09-27 1994-11-08 Pfizer Inc. Modified peptide derivatives conjugated at 2-hydroxyethylamine moieties
EP1910286A2 (en) * 2005-07-27 2008-04-16 F.Hoffmann-La Roche Ag Cathepsin k inhibitors
US20090004684A1 (en) * 2007-05-23 2009-01-01 Claudia Susanne Maier Compositions and Methods for Detection and Quantification of Protein Oxidation
WO2009129472A2 (en) * 2008-04-18 2009-10-22 University Of Pittsburgh Of The Commonwealth System Of Higher Education Methods of labeling biological samples
US20100105102A1 (en) * 2008-10-22 2010-04-29 Reveal Sciences, Llc Device, method and apparatus for analyzing skin and hair
EP2416702A2 (en) * 2009-04-07 2012-02-15 Reveal Sciences, Llc Device, method, and apparatus for biological testing with a mobile device
WO2011072197A2 (en) * 2009-12-11 2011-06-16 Purdue Research Foundation Detection of oxidized polypeptides
WO2012175519A1 (en) * 2011-06-20 2012-12-27 Universite Pierre Et Marie Curie (Paris 6) A method for detecting and/or quantifying carbonylated proteins
CN104020246A (zh) * 2014-06-24 2014-09-03 上海大学 同时检测大气中多种挥发性痕量羰基化合物的方法

Also Published As

Publication number Publication date
JP6970122B2 (ja) 2021-11-24
KR102408263B1 (ko) 2022-06-10
CA3013668A1 (en) 2017-11-23
SG11201807313PA (en) 2018-09-27
IL262322A (en) 2018-11-29
KR20190008853A (ko) 2019-01-25
IL262322B1 (en) 2023-09-01
AU2017267726A1 (en) 2018-08-16
US11371999B2 (en) 2022-06-28
EP3458855A1 (en) 2019-03-27
BR112018069072A2 (pt) 2019-01-22
IL262322B2 (en) 2024-01-01
WO2017201312A1 (en) 2017-11-23
CN109154597A (zh) 2019-01-04
US20190219590A1 (en) 2019-07-18
EP3458855C0 (en) 2025-04-30
EP3458855B1 (en) 2025-04-30
JP2019521328A (ja) 2019-07-25
CN109154597B (zh) 2022-06-24
AU2017267726B2 (en) 2023-09-14

Similar Documents

Publication Publication Date Title
SA518390949B1 (ar) طريقة لتحديد المسامية المرتبطة بمادة عضوية في بئر أو تكوين
EP3455741A4 (en) AUTOMATED ACCURACY ASSESSMENT FOR A TASK SYSTEM
WO2016196765A3 (en) Companion methods and kits for il-2-based therapies and mesenchymal stem cell-based therapies
CA2930450C (en) Protective cover for welding display
MX2017003189A (es) Metodos de gestion de salud y bienestar y sistemas utiles para la practica de los mismos.
MX343922B (es) Tratamiento de fallas en un vehículo autónomo.
IL281355B (en) Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm
MX2016013991A (es) Metodo y sistema para determinacion de humectabilidad resuelta espacialmente.
GB2540702A (en) Nucleic acid processing of a nucleic acid fragment with a triazole linkage
EP3538893A4 (en) PROCESSES FOR IDENTIFYING CANDIDATE BIOMARKERS
MY198754A (en) Improved customer profiling system and method therefor
IL254293A0 (en) A system for displaying peptides on the cell surface
EP3673383A4 (en) AUTOMATIC DATABASE ANALYSIS
SG10201810259RA (en) Roof coating system
TR201909125T4 (tr) Yüzey temi̇zlemek i̇çi̇n bi̇r aparat
EP3167081A4 (en) Multi-influenza detection kit and method for detecting influenza using the same
HK1231512A1 (zh) 检测样本中多种核酸的方法
MX2018013673A (es) Ensayo para determinar nivel de carbonilacion total en un polipeptido.
MX362149B (es) Determinacion de directrices de operacion basandose en una posicion de la superficie de carga.
EP3227664A4 (en) Multi-sample laser-scatter measurement instrument with incubation feature, and systems for using the same
MX377034B (es) Un eje de entrada entre un aparato y un aparato separado.
WO2015164826A3 (en) ASPARTATE-β-HYDROXYLASE INDUCES EPITOPE-SPECIFIC T CELL RESPONSES IN TUMORS
PL3802101T3 (pl) Podłoże bitumiczne dla przemysłu budowlanego
WO2015066189A3 (en) Modification of nuclear actin by mical-2 regulates srf signaling
WO2016001431A8 (en) In vitro assays for assessing cell aging